These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19283767)

  • 1. Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions.
    Ivanisevic I; Bates S; Chen P
    J Pharm Sci; 2009 Sep; 98(9):3373-86. PubMed ID: 19283767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative and quantitative methods to determine miscibility in amorphous drug-polymer systems.
    Meng F; Dave V; Chauhan H
    Eur J Pharm Sci; 2015 Sep; 77():106-11. PubMed ID: 26006307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of amorphous API:Polymer mixtures using X-ray powder diffraction.
    Newman A; Engers D; Bates S; Ivanisevic I; Kelly RC; Zografi G
    J Pharm Sci; 2008 Nov; 97(11):4840-56. PubMed ID: 18351626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.
    Qian F; Huang J; Hussain MA
    J Pharm Sci; 2010 Jul; 99(7):2941-7. PubMed ID: 20127825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.
    Overhoff KA; Moreno A; Miller DA; Johnston KP; Williams RO
    Int J Pharm; 2007 May; 336(1):122-32. PubMed ID: 17184938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling.
    Curtin V; Amharar Y; Hu Y; Erxleben A; McArdle P; Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2013 Jan; 10(1):386-96. PubMed ID: 23186332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical stability studies of miscible amorphous solid dispersions.
    Ivanisevic I
    J Pharm Sci; 2010 Sep; 99(9):4005-12. PubMed ID: 20533553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: a case study with itraconazole and eudragit e100.
    Janssens S; De Zeure A; Paudel A; Van Humbeeck J; Rombaut P; Van den Mooter G
    Pharm Res; 2010 May; 27(5):775-85. PubMed ID: 20195707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miscibility/stability considerations in binary solid dispersion systems composed of functional excipients towards the design of multi-component amorphous systems.
    Yoo SU; Krill SL; Wang Z; Telang C
    J Pharm Sci; 2009 Dec; 98(12):4711-23. PubMed ID: 19462469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.
    Meng F; Trivino A; Prasad D; Chauhan H
    Eur J Pharm Sci; 2015 Apr; 71():12-24. PubMed ID: 25686597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.
    Laitinen R; Löbmann K; Grohganz H; Strachan C; Rades T
    Mol Pharm; 2014 Jul; 11(7):2381-9. PubMed ID: 24852326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Differential Scanning Calorimetry, Powder X-ray Diffraction, and Solid-state Nuclear Magnetic Resonance Spectroscopy for Measuring Crystallinity in Amorphous Solid Dispersions - Application to Drug-in-polymer Solubility.
    Jarrells TW; Munson EJ
    J Pharm Sci; 2022 Oct; 111(10):2765-2778. PubMed ID: 35421430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data mining of solubility parameters for computational prediction of drug-excipient miscibility.
    Alhalaweh A; Alzghoul A; Kaialy W
    Drug Dev Ind Pharm; 2014 Jul; 40(7):904-9. PubMed ID: 23627441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of copolymer composition on the phase behavior of solid dispersions.
    Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
    Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of phase diagrams and physical stability of drug-polymer solid dispersions.
    Lu J; Shah S; Jo S; Majumdar S; Gryczke A; Kolter K; Langley N; Repka MA
    Pharm Dev Technol; 2015 Jan; 20(1):105-17. PubMed ID: 25113671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling as a predictive tool for the development of solid dispersions.
    Maniruzzaman M; Pang J; Morgan DJ; Douroumis D
    Mol Pharm; 2015 Apr; 12(4):1040-9. PubMed ID: 25734898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate Analysis of Solubility Parameters for Drug-Polymer Miscibility Assessment in Preparing Raloxifene Hydrochloride Amorphous Solid Dispersions.
    Moreira GG; Taveira SF; Martins FT; Wagner KG; Marreto RN
    AAPS PharmSciTech; 2024 Jun; 25(5):127. PubMed ID: 38844724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.